Abbott Must Face Suit Over Anticonvulsant Birth Defect Risks
An Illinois appellate panel on Thursday reversed a summary judgment win for Abbott Laboratories in a suit brought by a couple claiming it failed to sufficiently warn physicians that its anticonvulsant...To view the full article, register now.
Already a subscriber? Click here to view full article